Clone-specific T Cell Receptor Antagonists of Major Histocompatibility Complex Class I-restricted Cytotoxic T Cells
Overview
General Medicine
Authors
Affiliations
A previous report showed that the proliferative response of helper T cells to class II major histocompatibility complex (MHC)-restricted antigens can be inhibited by analogues of the antigen, which act as T cell receptor (TCR) antagonists. Here we define and analyze peptide variants that antagonize various functions of class I MHC-restricted cytotoxic T lymphocyte (CTL) clones. Of 64 variants at individual TCR contact sites of the Kb-restricted octamer peptide ovalbumin257-264 (OVAp), a very high proportion (40%) antagonized lysis by three OVAp-specific CTL clones. This effect was highly clone specific, since many antagonists for one T cell clone have differential effects on another. We show that this inhibition of CTL function is not a result of T cell-T cell interaction, precluding veto-like phenomena as a mechanism for antagonism. Moreover, we present evidence for direct interaction between the TCR and antagonist-MHC complexes. In further analysis of the T cell response, we found that serine esterase release and cytokine production are susceptible to TCR antagonism similarly to lysis. Ca2+ flux, an early event in signaling, is also inhibited by antagonists but may be more resistant to the antagonist effect than downstream responses.
Single-cell NAD(H) levels predict clonal lymphocyte expansion dynamics.
Turner L, Van Le T, Cross E, Queriault C, Knight M, Trihemasava K Sci Immunol. 2024; 9(93):eadj7238.
PMID: 38489349 PMC: 11064129. DOI: 10.1126/sciimmunol.adj7238.
Regulating the discriminatory response to antigen by T-cell receptor.
Gangopadhyay K, Roy S, Sen Gupta S, Chandradasan A, Chowdhury S, Das R Biosci Rep. 2022; 42(3).
PMID: 35260878 PMC: 8965820. DOI: 10.1042/BSR20212012.
HLA-DRB1 genes and the expression dynamics of HLA CIITA determine the susceptibility to T2DM.
Chinniah R, Sevak V, Pandi S, Ravi P, Vijayan M, Kannan A Immunogenetics. 2021; 73(4):291-305.
PMID: 33754173 DOI: 10.1007/s00251-021-01212-x.
Minigo G, Flanagan K, Slattery R, Plebanski M Front Immunol. 2017; 8:115.
PMID: 28261200 PMC: 5306364. DOI: 10.3389/fimmu.2017.00115.
Candia M, Kratzer B, Pickl W Int Arch Allergy Immunol. 2016; 170(4):211-233.
PMID: 27642756 PMC: 7058415. DOI: 10.1159/000448756.